Hepatitis C

Hepatitis C is a blood-borne virus that infects the liver, where it causes significant inflammation, damage and disruption of normal liver function. According to estimates by the World Health Organization, around 3 to 4 million people worldwide are infected with hepatitis C every year.
What is Hepatitis C?

Hepatitis C infection is a liver infection caused by the Hepatitis C virus. Infection with hepatitis C may damage the liver leading to chronic infection.

Read More

Overview

Feature Articles

Latest Hepatitis C News and Research

Extensive use of opioid agonists can considerably reduce drug-related deaths

Extensive use of opioid agonists can considerably reduce drug-related deaths

Current screening guidelines may not detect liver cancer soon enough in African Americans

Current screening guidelines may not detect liver cancer soon enough in African Americans

Insights into molecular tools shared across coronaviruses could provide potential target for COVID-19

Insights into molecular tools shared across coronaviruses could provide potential target for COVID-19

Neanderthal gene can confer protection against severe COVID-19, finds study

Neanderthal gene can confer protection against severe COVID-19, finds study

Researchers urge European policymakers to make adequate resources available to tackle pancreatic cancer

Researchers urge European policymakers to make adequate resources available to tackle pancreatic cancer

Inhibitors to target SARS-CoV-2 viral protein display strong antiviral activity in transgenic mouse model

Inhibitors to target SARS-CoV-2 viral protein display strong antiviral activity in transgenic mouse model

Probiotics may be beneficial in COVID-19 treatment

Probiotics may be beneficial in COVID-19 treatment

New tool enables study of SARS-CoV-2 mutant spectrum by ultrasequencing

New tool enables study of SARS-CoV-2 mutant spectrum by ultrasequencing

Phase 1 clinical trial of novel HIV vaccine approach shows promising results

Phase 1 clinical trial of novel HIV vaccine approach shows promising results

Oxysterol derivatives show powerful antiviral activity against SARS-CoV-2 in vitro

Oxysterol derivatives show powerful antiviral activity against SARS-CoV-2 in vitro

CoCID project aims to develop soft X-ray microscope for visualizing cellular origin of diseases

CoCID project aims to develop soft X-ray microscope for visualizing cellular origin of diseases

Increased access to testing, treatment has reduced hepatitis C in low- and middle-income countries

Increased access to testing, treatment has reduced hepatitis C in low- and middle-income countries

Viral ExoN regulates the rate of recombination in SARS-CoV-2

Viral ExoN regulates the rate of recombination in SARS-CoV-2

Remdesivir, given to half of hospitalized covid patients in U.S., is big win for Gilead  — boosted by taxpayers

Remdesivir, given to half of hospitalized covid patients in U.S., is big win for Gilead — boosted by taxpayers

COVID-19 has transformed the world of vaccines

COVID-19 has transformed the world of vaccines

Carbon-based nanomaterials as potential COVID-19 treatments

Carbon-based nanomaterials as potential COVID-19 treatments

Research suggests St. John's Wort and Echinacea could protect against COVID-19

Research suggests St. John's Wort and Echinacea could protect against COVID-19

Study: Frailty is a risk factor among women waiting for liver transplants

Study: Frailty is a risk factor among women waiting for liver transplants

FDA-approved COVID-19 drug should be used cautiously, says UC researcher

FDA-approved COVID-19 drug should be used cautiously, says UC researcher

HDL nanoparticles prevent cholesterol movement at membrane receptor to inhibit entry of SARS-CoV-2 pseudovirus in cell culture

HDL nanoparticles prevent cholesterol movement at membrane receptor to inhibit entry of SARS-CoV-2 pseudovirus in cell culture